Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News QuidelOrtho Corp QDEL

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies... see more

Recent & Breaking News (NDAQ:QDEL)

Quidel to Hold Third Quarter 2014 Financial Results Conference Call on October 21, 2014

Marketwired October 6, 2014

Quidel to Present at Baird 2014 Health Care Conference

Marketwired August 22, 2014

Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test for Group A Strep

Marketwired July 28, 2014

Quidel Reports Second Quarter 2014 Financial Results

Marketwired July 22, 2014

Quidel to Hold Second Quarter 2014 Financial Results Conference Call on July 22, 2014

Marketwired July 8, 2014

Quidel to Present at Wells Fargo Securities 2014 Healthcare Conference

Marketwired June 4, 2014

Quidel Receives CLIA Waiver for Its Sofia(R) Diagnostic Test for Respiratory Syncytial Virus (RSV)

Marketwired June 2, 2014

Quidel Receives FDA Clearance for Its Molecular PCR Assay for the Detection of Herpes Simplex Virus 1+2 and Varicella Zoster Virus

Marketwired May 14, 2014

Quidel to Present at Bank of America Merrill Lynch 2014 Health Care Conference

Marketwired April 29, 2014

Quidel Reports First Quarter 2014 Financial Results

Marketwired April 23, 2014

Quidel Reports First Quarter 2014 Financial Results

Marketwired April 23, 2014

Quidel Receives FDA Clearance for Its Lyra(TM) Molecular PCR Assay for the Detection of Infections From Pyogenic Streptococcus Group A and C or G

Marketwired April 22, 2014

Quidel Receives FDA Clearance for Its Lyra(TM) Molecular PCR Assay for the Detection of Infections From Pyogenic Streptococcus Group A and C or G

Marketwired April 22, 2014

Quidel to Hold First Quarter 2014 Financial Results Conference Call on April 23, 2014

Marketwired April 15, 2014

Quidel to Hold First Quarter 2014 Financial Results Conference Call on April 23, 2014

Marketwired April 15, 2014

Quidel Receives FDA Clearance for Its AmpliVue(R) Hand-Held Molecular Diagnostic Test for Herpes Simplex Virus Types 1 and 2

Marketwired March 27, 2014

Quidel Receives FDA Clearance for Its AmpliVue(R) Hand-Held Molecular Diagnostic Test for Herpes Simplex Virus Types 1 and 2

Marketwired March 27, 2014

Quidel to Present at Cowen 34th Annual Health Care Conference

Marketwired February 18, 2014

Quidel Reports Fourth Quarter and Full Year 2013 Financial Results

Marketwired February 11, 2014

Quidel to Hold Fourth Quarter and Full Year 2013 Financial Results Conference Call on February 11, 2014

Marketwired January 28, 2014